La plate-forme oncoXchange est maintenant disponible en français! Le contenu de la version anglaise peut ne pas être traduit dans son intégralité.
ESMO 2024: Dr. Cristina Saura: Key ESMO Findings on Breast Cancer Trials & Breastfeeding Safety
Dr. Cristina Saura highlights three key messages from the ESMO 2024 meeting, focusing on significant advancements in breast cancer research. First, the results of the DESTINY-Breast12 trial showcased new treatment options for advanced breast cancer. Second, the ICARUS-BREAST01 study provided further insights into innovative therapeutic approaches. Lastly, she emphasized two groundbreaking international studies that confirmed breastfeeding after breast cancer treatment does not increase the risk of recurrence or new cancers, marking an important step for young survivors seeking safe breastfeeding options.